Rueckersdorf, Germany

Stefan Löber

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Other. Active years: 2011.



Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:

goldMedal1 out of 834,411 
Other
 patents

Years Active: 2011

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Stefan Löber

Introduction

Stefan Löber is a notable inventor based in Rueckersdorf, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target misfolded proteins. His work is crucial in addressing diseases associated with protein misfolding, which can lead to various health issues.

Latest Patents

One of Stefan Löber's key patents is focused on 9-amino-acridine derivatives and their use for eliminating misfolded proteins. This invention relates to compounds according to a general formula and includes their enantiomers, diastereomers, and pharmaceutically compatible salts. The patent outlines the use of these compounds in producing a medicament suited for treating diseases linked to misfolded proteins. He holds 1 patent in this area.

Career Highlights

Throughout his career, Stefan Löber has worked with various companies, contributing his expertise to advance medicinal research. His innovative approach has led to the development of new therapeutic options for challenging medical conditions.

Collaborations

Stefan has collaborated with notable professionals in his field, including Carsten Korth and Ralf Klingenstein. These partnerships have enhanced his research and contributed to the successful development of his inventions.

Conclusion

Stefan Löber's work in the field of medicinal chemistry exemplifies the impact of innovation on healthcare. His contributions, particularly in the area of misfolded proteins, highlight the importance of continued research and development in addressing complex medical challenges.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…